Greatmark Investment Partners, Inc.
Source: SEC Form 13F · as of Mar 2026Greatmark Investment Partners, Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $84.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$84.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 116,670 | $28.5M |
| AMGNAMGEN INC | 71,023 | $25.0M |
| ELVElevance Health Inc. | 38,622 | $11.3M |
| ABBVAbbVie Inc. | 37,962 | $8.3M |
| GILDGILEAD SCIENCES, INC. | 28,690 | $4.0M |
| LLYELI LILLY & Co | 2,689 | $2.5M |
| ZBHZimmer Biomet Holdings Inc. | 20,071 | $1.8M |
| PMPhilip Morris International Inc | 4,177 | $691K |
| MRKMerck & Co., Inc. | 3,806 | $458K |
| ABTABBOTT LABORATORIES | 4,114 | $422K |
| AZNASTRAZENECA PLC | 1,821 | $359K |
| MCKMcKesson Corporation | 325 | $281K |
| PFEPFIZER INC | 9,621 | $270K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 765 | $207K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.